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Abstract The proteolytic processes involved in the conversion of procathepsin L to cathepsin L on a negatively charged surface, dextran sulfate, 
were studied. Upon incubation for 30 min at 37”C, pH 5.5 with dextran-sulfate and dithiothreitol, purified procathepsin L showed maximal activation 
and, correspondingly, the complete conversion to the 30 kDa, single chain mature form of enzyme was observed. In contrast, incubation under the 
same conditions on ice rather than at 37°C for 30 or 60 min resulted in partial proteolysis to produce a 31 kDa form without a significant increase 
in activity. Amino terminal amino acid sequence analyses howed that the 30 kDa form obtained by incubation at 37°C corresponds to the purified 
form of mature cathepsin L with a 2 amino acid extension at the amino terminal, and that the 3 1 kDa form generated by incubation on ice possesses 
a 6 amino acid amino terminal extension, suggesting that the activation and processing of procathepsin L are different processes, and that 4 amino 
acid residues (Glu-Pro-Leu-Met) at the carboxyterminal in the propeptide function to prevent the activation of processed cathepsin L. 
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1. Introduction 
Cathepsin L is the most potent cysteine proteinase and plays 
a major role in the lysosomal proteolysis of both endocytosed 
and endogenous proteins [l]. cDNA cloning and amino acid 
sequence analysis show cathepsin L to have a long prepro- 
sequence in front of the mature enzyme [2,3]. Pulse-chase xper- 
iments with different types of cells suggest hat the nzyme is 
translated in a prepro-form, is then processed into the pro- 
enzyme in the rough endoplasmic reticulum, and then localizes 
in lysosomes as the active enzyme [4,5]. It has been reported 
that l,lO-phenanthrolin and pepstatin partially inhibit the 
processing of the pro-form to the mature enzyme and it was 
speculated that metallo-proteinases or as an aspartic proteinase 
such as cathepsin D are involved in processing [6,7]. An in vitro 
study of purified procathepsin L isolated from conditioned 
medium of cultured murine fibroblasts showed the enzyme to 
become autocatalytically activated at pH 3.0 [8], a finding also 
demonstrated for guinea pig sperm cathepsin L [9]. On the 
other hand, considerable amounts of procathepsin L are se- 
creted into the medium in v-ras-transformed fibroblasts and 
cells stimulated by growth factors, and this secreted procathep- 
sin L is thought to be proteolytically processed to the active 
enzyme [8,10], but the mechanism is unknown. Thus, it remains 
to be demonstrated how the activation and processing of 
cathepsin L occur both intracellularly and extracellularly. 
Mason and Massey showed that procathepsin L is autoacti- 
vated by contact with negatively charged materials such as 
dextran sulfate at the physiological lysosomal pH at 5.5 [ll]. 
This system is thought to most closely resemble to the physio- 
logical state. Previously, we obtained procathepsin L-specific 
antibodies that recognize procathepsin L but not cathepsin L 
[12]. In this study using two antibodies, procathepsin L-specific 
antibodies and antibodies against mature cathepsin L which 
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Abbreviations: SDS-PAGE, polyacrylamide gel electrophoresis in the 
presence of sodium dodesyl sulfate; Z-FR-MCA, carbobenzoxy+ 
phenylalanyl+arginine 4-methylcoumaryl-7-amide; AMC, 7-amino- 
4-methyl-coumarin; SDS, sodium dodesyl sulfate. 
recognize both procathepsin L and mature cathepsin L, we 
show that the n gatively charged surface-mediated processing 
of procathepsin L occurs in at least two steps. 
2. Materials and methods 
The materials used in this study were obtained as follows: Z-FR- 
MCA and AMC from Peptide Institute (Osaka); dextran sulfate and 
CM-Sephadex C-50 from Pharmacia LKB Biotechnology (UK); ECA 
immunoblot detection kit from Amersham; BCA protein assay reagent 
from Pierce; Biogel P-60 from BioRad, and other reagents from Wako 
Pure Chemical Industries (Osaka). The generation of the anti-cathepsin 
L and procathepsin L-specific antibodies was described previously 1121. 
Procathepsin L was purified from v-Ha-ras transformed NIH3T3 cell 
conditioned medium as described previously [12]. Purified procathepsin 
L was stored at pH 7.5 at -80°C. Cathepsin L was purified from the 
same cells as follows. Cells grown until near confluence were collected 
with a cell scraper, washed twice with phosphate-buffered saline, and 
suspended in 10 volumes of 50 mM sodium acetate buffer @H 5.5) 
containing 1 mM EDTA. After cell disruption by sonication, the homo- 
genate was centrifuged at 18,500 x g for 10 min at 4°C and the super- 
natant was applied to a Biogel P-60 gel filtration column previously 
equibrated with 50 mM sodium acetate buffer (pH 5.5), 1 mM EDTA, 
200 mM NaCl. Active fractions were combined and concentrated by 
ultrafiltration using a YMlO membrane. After dialysis against 50 mM 
sodium acetate buffer (pH 5.5) containing 1 mM EDTA, the sample 
was fractionated on CM-Sephadex C-50 with a linear gradient from 100 
mM to 400 mM NaCl in 50 mM sodium acetate buffer (pH 5.5) contain- 
ing 1 mM EDTA. Active cathepsin L was eluted at approximately 250 
mM NaCl. Further purification was carried ou with ConA coupled to 
Affigel P-10. Cathepsin L was eluted with 0.5 M cc-methyl-mannoside 
in 50 mM sodium acetate buffer (PH 5.5) containing 1 mM EDTA and 
0.2 M NaCl. 
Processing of procathepsin L on the negatively-charged surface was 
performed according to the method of Mason and Massey [ll]. In 
short, 1 mg of purified procathepsin L, 500 ng of dextran sulfate in 50 
~1 of 100 mM sodium acetate buffer @H 5.5), and 1 mM dithiothreitol 
were incubated at 37°C for 30 min or on ice for 30 min or 60 min, and 
then aliquots of the reaction mixtures were subjected to enzyme assay 
as follows. Assay mixtures containing 100~1 of 100 mM sodium acetate 
buffer (pH 5.5) 4 mM cysteine, 100 mM Z-FR-MCA were preincu- 
bated at 37°C for 5 min and the reaction was initiated by the addition 
of 2.5 ~1 procathepsin L. To avoid activation of procathepsin L during 
incubation, the enzyme reaction was stopped after 2 min by the addition 
of SDS at a final concentration of 5%. The mixture was then diluted 
with 2 ml of 0.1 M Tris-HCl @H 9.0) and the released AMC was 
measured by fluorescence spectrophotometry at an excitation wave 
length of 370 nm and an emission wave length of 460 nm. For SDS- 
PAGE and immunoblot analyses, the reaction was stopped by the 
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addition of leupeptin at a final concentration of 10 mM. SDS-PAGE 
was performed according to the method of Laemmli [13] and im- 
munoblot analyses were carried out by the method of Towbin et al. [14]. 
For amino terminal amino acid sequence analysis, the proteins were 
subjected to electrophoresis on 15% acrylamide gels containing 1% 
SDS, and transferred electrophoretically onto Pro Blot membrane. 
After stained with Coomassie brilliant blue G-250, the proteins were 
cut out with a razor and destained with 50% methanol. After drying in 
a freezer, the samples were analyzed on a protein sequencer, Applied 
Biosystem Model 47lA. 
3. Results 
3.1. In vitro activation and processing of procathepsin L 
Cathepsin L has been purified from various mammalian tis- 
sues including liver, brain, and spleen, and from E. coli carrying 
an expression vector bearing the cDNA for cathepsin L [ 15-171. 
The specific activities of these purified samples determined 
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using the synthetic substrate, Z-FR-MCA have been reported 
to range between 22.5 and 34.4 nmol of AMC released/min/mg 
protein. Our purified preparation of cathepsin L from v-Ha-ras 
transformed NIH3T3 cells has a specific activity of 97.5 nmol 
of AMC released/min/mg protein, which is at least three times 
higher than that of the purified enzyme reported previously 
(Fig. la, Control). 
Purified procathepsin L is apparently homogeneous and de- 
tected as a single band with a molecular weight of 39 kDa by 
both the procathepsin L-specific antibody and the anti-cathep- 
sin L antibody that recognized both procathepsin L and mature 
cathepsin L (Fig. lb, lane 2). The specific activity of procathep- 
sin L was estimated to be 10.10 + 0.92 nmol of AMC released/ 
min/mg protein (Fig. la, column l), ten times lower than that 
of purified cathepsin L. AMC release was linear for the first 
3 min, but hyperbolic after 5 min (data, not shown). To avoid 





Fig. 1. Activation and processing of procathepsin L in the presence of dextran sulfate. (a) Purified procathepsin L (column 1) was incubated on ice 
for 30 min (2) or 60 min (3) or at 37°C for 30 min (4) in the presence of dextran sulfate and dithiothreitol. After incubation, aliquots of the mixtures 
were subjected to enzyme assay. Proteolytic activity was measured uring 2 min of incubation to avoid activation of procathepsin L. Control shows 
the activity of purified cathepsin L. (b) The same reaction mixtures after activation on ice or 37°C were subjected to SDS-PAGE and immunoblotting 
after the addition of leupeptin. Electrophoresis was performed in a 15% gel containing 1% SDS and 2-mercaptoethanol and the proteins were visualized 
with silver staining (A) or detected by immunoblotting using procathepsin L-specific antibody(B) or anti-cathepsin L antibody (C). Molecular markers 
used were: 97.4 kDa, phosphorylase b; 66.0 kDa, bovine serum albumin; 45.0 kDa, ovalbumin; 21.5 kDa, carbonic anhydrase; 14.5 kDa, soybean 
trypsin inhibitor. 
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activation of procathepsin L, the activity was measured uring 
2 min incubation. This value is the maximal activity of pro- 
cathepsin L, since the possibility that purified procathepsin L 
contains amounts of active cathepsin L undetectable on SDS- 
PAGE and immunoblotting with anti-cathepsin L antibody can 
not be ruled out. Mason and Massey [12] also reported that 
procathepsin L has little activity and that this activity is respon- 
sible for the initiation of activation, based on the incorporation 
of radioactive inhibitor into procathepsin L. 
Upon incubation at 37°C in the presence of dextran sulfate, 
procathepsin L is reported to be autocatalytically converted to 
the active form at pH 5.5 [l 11. We chose two incubation temper- 
atures, 37°C and ‘on ice’, in order to identify the relationship 
between activity and proteolytic processing. Incubation at 
37°C pH 5.5 for 30 min produced the maximal activation (Fig. 
la, column 4). The specific activity was determined to be 
69.92 ? 2.52 nmol of AMC released/min/mg protein, about 
70% of the activity of purified cathepsin L. In parallel with 
activation, the proteolytic maturation of procathepsin L to the 
mature single chain form of the enzyme with an apparent mo- 
lecular mass of 30 kDa was observed (Fig. lb, lane 4). Im- 
munoblotting analyses with antibodies against both cathepsin 
L and procathepsin L confirmed that procathepsin L is con- 
verted completely to a 30 kDa form (Fig. lb, lanes 3 and 4). 
When the procathepsin L was incubated at pH 5.5 on ice for 
30 min, the activity was somewhat lower (6.65 f 0.61 nmol of 
AMC released/min/mg protein) than procathepsin L (Fig. la, 
column 2). Statistical analysis by the computer package 
ANOVA in Statview II revealed this difference to be significant 
at the 95% level. Incubation on ice for 60 min showed a specific 
(kDa.) 1 2 3 4 
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Fig. 2. Effects of leupeptin on the processing of procathepsin L. Pro- 
cathepsin L was processed in dextran sulfate and dithiothreitol at pH 
5.5 for 30 min in the absence (lanes 1 and 3) or presence (lanes 2 and 
4) of 10 mM leupeptin. Incubation at 37°C (lanes 1 and 2) or on ice 
(lanes 3 and 4). Electrophoresis was performed as in Fig. 1 and proteins 
in the gel were stained with silver. For molecular markers, see the legend 





Fig. 3. Amino terminal sequences of the processed forms of procathep- 
sin L. The amino acid sequence of the carboxyl end region of the 
propeptide of mouse procathepsin L is shown. Numbers above the 
sequence start at the amino terminus of purified cathepsin L and nega- 
tive numbers indicate the amino acid sequence of thepropeptide region. 
The amino acid seauences of the 31 kDa and 30 kDa forms produced 
by incubation for i0 min on ice and at 37°C for 30 min, respectively, 
are shown by arrows. (A) 31 kDa form and (B) 30 kDa form. 
activity of 8.9 f 2.56 nmol of AMC released/min/mg protein, 
comparable to that of procathepsin L (Fig. 1 column 3). Fur- 
ther incubation at 37°C for 30 min after standing on ice for 30 
min produced the maximal activation comparable to column 
4 (data not shown). 
The results after 30 and 60 min incubation on ice in the 
presence of dextran sulfate are interesting since the partial 
proteolytic processing occurred despite the fact that there was 
no activation. In addition to the non-proteolysed procathepsin 
L of 39 kDa, a 31 kDa protein that cross-reacted with the 
cathepsin L antibody, but not he procathepsin L-specific anti- 
body, was detected (Fig. lb, lanes 2 and 3). 
Fig. 2 shows that the dextran sulfate-mediated processing of 
procathepsin L at 37°C and on ice is completely inhibited by 
the cysteine proteinase inhibitor leupeptin. Other inhibitors 
tested, PMSF, a serine proteinase inhibitor, pepstatin A, an 
aspartic proteinase inhibitor, and EDTA, a metalloproteinase 
inhibitor, had no effect on the processing of procathepsin L 
(data not shown). Purified preparations of procathepsin L con- 
tained no cathepsin B, H, S or C activities. The results suggest 
that processing of procathepsin L that occurs during incuba- 
tion at 37°C and on ice is autocatalytic. 
3.2. Amino-terminal amino acid sequences of the processed 
forms 
To compare the two processed forms of 31 kDa and 30 kDa 
generated by incubation on ice and at 37°C respectively, the 
two proteins were subjected to amino acid sequence analysis. 
(Fig. 3). The amino-terminal sequence of the 3 1 kDa polypep- 
tide obtained by autoprocessing on ice was determined to be 
Glu-Pro-Leu-Met-Leu-Lys-Ile-Pro-Lys-Ser---, identical to the 
6 amino acid residues upstream of the amino terminal isoleuc- 
ine of purified mature mouse cathepsin L. In contrast, the 
amino-terminal sequence of the 30 kDa polypeptide produced 
by incubation at 37°C was found to be Leu-Lys-Ile-Pro-Lys- 
Ser-Val-Asp-Trp-Arg-Glu---, which corresponds to a two 
amino acid amino terminal extension of mature cathepsin L. 
The proteolytic activities of the two processed forms were quite 
different and full activation of the 31 kDa form was obtained 
by further incubation at 37°C for 30 min. Thus, a 4 amino acid 
(Glu-Pro-Leu-Met) amino terminal extension might be in- 
volved in inhibiting the expression of the Z-Phe-Arg-MCA 
hydrolyzing activity. A search with the computer package 
GeneWorks in the SWISS PROT amino acid sequence data 
bank produced more than forty proteins, including mouse and 
rat procathepsin L, that contain the 4 amino acid sequence 
Glu-Pro-Leu-Met. Among proteinases, only a metallopro- 
teinase, thimet oligopeptidase (EC.3.4.24.15) contains this 
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amino acid sequence motif. None of the endogenous cysteine 
proteinase inhibitors, including members of the cystatin super- 
family possess, this sequence. 
4. Discussion 
There have been several suggestions made about the func- 
tions of the propeptide of lysosomal cysteine proteinases. In 
experiments where the cDNA for mouse cathepsin L was ex- 
pressed in E. cofi, truncation of the pre-peptide region was 
shown to restore proteolytic activity after renaturation, 
whereas truncation of the pro-peptide region did not lead to 
activity recovery, suggesting that the pro-peptide is necessary 
for the three dimensional structure of the cysteine proteinase 
[17]. Tao et al. [18] constructed cathepsin L cDNAs encoding 
proteins with altered pro-regions and expressed them in COS 
cells. They showed that cathepsin L proteins with altered pro- 
regions display differences in protein folding, endoplasmic 
reticulum exit, stability and mannose phosphorylation. A re- 
cent report demonstrated that in addition to mannose 6-phos- 
phate receptor-mediated transport of procathepsin L to lyso- 
somes, another translocation signal to lysosomes is localized in 
some segment of the pro-peptide region [19]. A third function 
is inhibitory activity of the pro-peptide as discussed here. Puri- 
fied procathepsin L has less than 10% of the activity of purified 
cathepsin L, but removal of the pro-peptide leads to almost full 
activity. This suggests that the full-length pro-peptide is poten- 
tially inhibitory. 
Incubation of procathepsin L with dextran-sulfate on ice 
generates the processed form of procathepsin L with a 6 amino 
acid amino terminal extension on the mature cathepsin L. This 
form of the enzyme is inactive with two-thirds of the activity 
of purified procathepsin L. Further incubation at 37°C pro- 
duced the active processed form. This form, produced by incu- 
bation at 37°C for 30 min, has a 2 amino acids extension at the 
amino terminal of the mature enzyme. This suggests that the 
removal of a four amino acid extension causes activation of the 
processed form. Cathepsin L cleaves at hydrophobic residues 
occupying sites S2 and S3 of peptide substrates [20]. The Leu- 
Met at the carboxyl end of the 4 amino acid extension sequence 
is identical to that present at one of the major cleavage sites of 
the peptide substrate, glucagon [21]. Thus, the four residue 
peptide might act as a ‘pseudosubstrate’ to inactivate of proc- 
essed procathepsin L. Although the homology of the entire 
propeptide region of lysosomal cysteine proteinases is about 
25%, this four residue peptide at the carboxyl end of the 
propeptide lacks sequence homology [22], also supporting the 
‘pseudo-substrate’ model. 
In this paper, we show that procathepsin L is activated in 
conctact with dextran-sulfate at a physiological ysosomal pH 
of 5.5, and that the processing proceeds through the generation 
of an inactive processing intermediate, suggesting the occur- 
rence of multiple autocatalytic cleavage steps. It is, however, 
uncertain whether the results obtained in vitro experiments can 
be reproduced in vivo. We are now conducting experiments 
using various antibodies that recognize specific cleavage sites 
of the propeptide to determine whether multiple autocatalytic 
processing of procathepsin L occurs in vivo and, if it does, 
where it occurs. 
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